Stockholders' Equity (Tables)

12 Months Ended

Jun. 30, 2025

Stockholders' Equity

Dividends declared and paid

	Fiscal Year
	2025		2024
Fourth fiscal quarter	$	0.12	$	0.12
Third fiscal quarter		0.12		0.12
Second fiscal quarter		0.12		0.12
First fiscal quarter		0.12		0.12

Schedule of share repurchases

	Years Ended June 30,
	2025		2024
Number of treasury shares acquired(1)		89		202
Average cost per share(1)	$	5.01	$	5.66
Total cost of treasury shares acquired	$	442	$	1,144

(1) For the year ended June 30, 2024, includes 140,672 shares repurchased under the Company’s share repurchase program for a weighted average price of $5.33 per share.

Schedule of Market-based Award Valuation Assumptions

	Years Ended June 30,
	2025		2024
Weighted average fair value of performance-based awards granted	$	3.90	$	3.58
Risk-free interest rate		3.45%		4.87%
Expected term in years		2.78		2.77
Expected volatility		50.2%		55.0%
Dividend yield		8.4%		7.4%

Schedule of restricted stock transactions

		Weighted
	Number of	Average
	Restricted	Grant-Date
Award Type	Shares	Fair Value
Time-vested awards	348,143	$	6.29
Performance-based awards	322,142		4.81
Unvested at June 30, 2025	670,285	$	5.58

Restricted Stock

Stockholders' Equity

Schedule of restricted stock transactions

The following table sets forth the restricted stock award transactions for the years ended June 30, 2025 and 2024:

						Weighted
		Weighted		Unamortized		Average
	Number of	Average		Compensation		Remaining	Aggregate Intrinsic
	Restricted	Grant-Date		Expense		Amortization	Value (1)
	Shares	Fair Value		(In thousands)		Period (Years)	(In thousands)
Unvested at June 30, 2023	595,414	$	6.48
Time-vested shares granted	157,692		6.22
Performance-based shares granted	136,315		4.80
Vested	(260,910)		5.85
Unvested at June 30, 2024	628,511	$	6.31	$	2,492	1.8	$	3,312
Time-vested shares granted	187,155		5.70
Performance-based shares granted	189,477		4.82
Vested	(326,431)		6.60
Forfeited	(8,427)		6.05
Unvested at June 30, 2025	670,285	$	5.58	$	2,196	1.6	$	3,150

(1) The intrinsic value of restricted stock was calculated as the closing market price on June 30, 2025 and 2024 of the underlying stock multiplied by the number of restricted shares that would be issuable. The total fair value of shares vested was $1.7 million and $1.6 million for the years ended June 30, 2025 and 2024, respectively.

Contingent restricted stock grants

Stockholders' Equity

Schedule of restricted stock transactions

The following table sets forth contingent restricted stock unit transactions for the years ended June 30, 2025 and 2024:

						Weighted
				Unamortized		Average
	Number of	Weighted Average		Compensation		Remaining	Aggregate Intrinsic
	Restricted	Grant-Date		Expense		Amortization	Value (1)
	Stock Units	Fair Value		(In thousands)		Period (Years)	(In thousands)
Unvested at June 30, 2023	96,398	$	3.49
Performance-based awards granted	102,239		1.95
Expired	(47,849)		2.19
Unvested at June 30, 2024	150,788	$	2.86	$	230	1.6	$	795
Performance-based awards granted	142,112		2.67
Forfeited	(3,394)		2.91
Expired	(47,893)		4.77
Unvested at June 30, 2025	241,613	$	2.37	$	340	1.8	$	1,136

(1) The intrinsic value of contingent restricted stock units was calculated as the closing market price on June 30, 2025 and 2024 of the underlying stock multiplied by the number of restricted shares that would be issuable.